This year the 16-ICML, the most important International Conference on Malignant Lymphoma, will be online!
We were hoping to meet personally in Lugano, but are just as excited to provide you the most recent and significant data in the field of lymphoma through a brand new and engaging digital experience.
We are confident we will deliver the high-quality scientific experience you expect from ICML year after year and look forward to welcoming you on the 16-ICML Virtual Platform!
Franco Cavalli Francesco Bertoni
ICML President Organizing Committee Chairman
The 16-ICML will be broadcasted on a virtual platform that will be accessible from the homepage of this website from June 16 at 10:00 (CEST).
The access is restricted to 16-ICML attendees, faculty and sponsors.
The meeting objectives and learning outcomes are:
- Acquaintance with the latest advances in basic science regarding lymphoma
- Learning about recent results of translational research in lymphoma
- Be informed on the most recent data from clinical studies
- Fostering discussion and sharing of ideas among attendees about innovations in the field of lymphoma
- Spreading evidence-based knowledge of primary clinical relevance
The content of the Program aims to:
- Provide information that is useful to the work of participants and relevant to practice techniques
- Present well-balanced data supported by adequate evidence
- Allow time for discussion and questions
The last edition of the ICML Congress (15-ICML) brought together about 3’500 physicians from all over the world: hematologists, clinical oncologists, radiation oncologists, pediatricians, pathologists and leading researchers involved in the study and treatment of lymphoid neoplasms.
Please note that the 16-ICML Industry Program is intended only for healthcare professionals involved in the study and treatment of lymphoid neoplasms.
The Advisory Board gathers lymphoma experts and specialists from around the world. Their role is fundamental in the development of the ICML Scientific Program, helping the Organizing Committee to ensure not only the impartiality of the evaluation but also the multiplicity of approaches and skills.
The members of the Board contribute to the choice of topics and speakers and evaluate the submitted abstracts. During the days of the Conference they collaborate by introducing special lectures and moderating the sessions.
Members of 16-ICML Advisory Board:
James O. Armitage, Omaha, NE (USA) – Chairman
Helmut Beltraminelli, Locarno (Switzerland)
Elias Campo, Barcelona (Spain)
Bruce D. Cheson, Washington, D.C. (USA)
Nicholas Chiorazzi, Manhasset, NY (USA)
Wee Joo Chng, Singapore (Singapore)
Riccardo Dalla-Favera, New York, NY (USA)
Stephan Dirnhofer, Basel (Switzerland)
Martin Dreyling, Munich (Germany)
Jonathan W. Friedberg, Rochester, NY (USA)
Gianluca Gaidano, Novara (Italy)
Philippe Gaulard, Créteil (France)
Mary K. Gospodarowicz, Toronto, ON (Canada)
Peter W.M. Johnson, Southampton (UK)
Brad S. Kahl, St. Louis, MO (USA)
Ralf Küppers, Essen (Germany)
John P. Leonard, New York, NY (USA)
T. Andrew Lister, London (UK)
Markus G. Manz, Zurich (Switzerland)
Ari M. Melnick, New York, NY (USA)
Koichi Ohshima, Kurume (Japan)
Astrid Pavlovsky, Buenos Aires (Argentina)
Leticia Quintanilla-Martinez de Fend, Tübingen (Germany)
S. Vincent Rajkumar, Rochester, MN (USA)
Kerry J. Savage, Vancouver, BC (Canada)
John F. Seymour, Melbourne (Australia)
Margaret A. Shipp, Boston, MA (USA)
Lena Specht, Copenhagen (Denmark)
Catherine Thieblemont, Paris (France)
Pier Luigi Zinzani, Bologna (Italy)
Wilhelm Wössmann, Hamburg (Germany)
Weili Zhao, Shanghai (China)
16-ICML participants will be able to download the certificate of attendance from the 16-ICML Virtual Platform (MyProfile section), after completing the evaluation form.
ICML is not accredited with European CME.
The 16-ICML Program will be part of the fourth edition of the Certificate of Competence in Lymphoma, a 14-month European Credit Transfer and Accumulation System (ECTS) program developed by the European School of Oncology (ESO) and academically recognized by the University of Ulm. The purpose of the Certificate of Competence is to provide a curriculum of studies to advance knowledge and science in the management of lymphoma patients.
For further information: contact the ESO Bellinzona office.
Sponsors of Italian delegates who need an AIFA pre-request should address their requests to:
Aria di Viaggi di Atlante Viaggi Italia Srl
via Matteo Bandello 1 - 20123 Milan (Italy)
P.I. 02818040152 - IATA 38220346
tel. +39 02 4818692